Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment.

@article{Caudell2008LocoregionallyAH,
  title={Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment.},
  author={Jimmy J. Caudell and Stephen M. Sawrie and Sharon A. Spencer and Renee Ann Desmond and William T. Carroll and Glenn E Peters and Lisle M Nabell and Ruby F. Meredith and James A. Bonner},
  journal={International journal of radiation oncology, biology, physics},
  year={2008},
  volume={71 3},
  pages={676-81}
}
PURPOSE The addition of platinum-based chemotherapy (ChRT) or cetuximab (ExRT) to concurrent radiotherapy (RT) has resulted in improved survival in Phase III studies for locoregionally advanced head and neck cancer (LAHNC). However the optimal treatment regimen has not been defined. A retrospective study was performed to compare outcomes in patients who were treated definitively with ExRT or ChRT. METHODS Cetuximab with concurrent RT was used to treat 29 patients with LAHNC, all of whom had… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

A comparison of concurrent cisplatin versus cetuximab with radiotherapy in locally-advanced head and neck cancer: A bi-institutional analysis.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology • 2017

Expression of Lysyl Oxidase Predictive of Distant Metastasis of Laryngeal Cancer.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery • 2017
View 2 Excerpts

Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer • 2016

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2007
View 1 Excerpt

Do patients with localized prostate cancer treatment really want more aggressive treatment?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2006
View 1 Excerpt

Factors contributing to frailty: Literature review

M Levers, CA Estabrooks, JC. Ross Kerr
J Adv Nurs 2006;56:282–291 • 2006
View 1 Excerpt

Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2005
View 2 Excerpts

The relationship of cetuximabinduced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximab [Abstract

J Bonner, P Harari, J Giralt
Int J Radiat Oncol Biol Phys 2005;63(Suppl):S73 • 2005
View 1 Excerpt

Similar Papers

Loading similar papers…